Cargando…
Use of ECMO for Cardiogenic Shock in Pediatric Population
In children with severe advanced heart failure where medical management has failed, mechanical circulatory support in the form of veno-arterial extracorporeal membrane oxygenation (VA ECMO) or ventricular assist device represents life-sustaining therapy. This review provides an overview of VA ECMO u...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068254/ https://www.ncbi.nlm.nih.gov/pubmed/33917910 http://dx.doi.org/10.3390/jcm10081573 |
_version_ | 1783682992987701248 |
---|---|
author | Bhaskar, Priya Davila, Samuel Hoskote, Aparna Thiagarajan, Ravi |
author_facet | Bhaskar, Priya Davila, Samuel Hoskote, Aparna Thiagarajan, Ravi |
author_sort | Bhaskar, Priya |
collection | PubMed |
description | In children with severe advanced heart failure where medical management has failed, mechanical circulatory support in the form of veno-arterial extracorporeal membrane oxygenation (VA ECMO) or ventricular assist device represents life-sustaining therapy. This review provides an overview of VA ECMO used for cardiovascular support including medical and surgical heart disease. Indications, contraindications, and outcomes of VA ECMO in the pediatric population are discussed.VA ECMO provides biventricular and respiratory support and can be deployed in rapid fashion to rescue patient with failing physiology. There have been advances in conduct and technologic aspects of VA ECMO, but survival outcomes have not improved. Stringent selection and optimal timing of deployment are critical to improve mortality and morbidity of the patients supported with VA ECMO. |
format | Online Article Text |
id | pubmed-8068254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80682542021-04-25 Use of ECMO for Cardiogenic Shock in Pediatric Population Bhaskar, Priya Davila, Samuel Hoskote, Aparna Thiagarajan, Ravi J Clin Med Review In children with severe advanced heart failure where medical management has failed, mechanical circulatory support in the form of veno-arterial extracorporeal membrane oxygenation (VA ECMO) or ventricular assist device represents life-sustaining therapy. This review provides an overview of VA ECMO used for cardiovascular support including medical and surgical heart disease. Indications, contraindications, and outcomes of VA ECMO in the pediatric population are discussed.VA ECMO provides biventricular and respiratory support and can be deployed in rapid fashion to rescue patient with failing physiology. There have been advances in conduct and technologic aspects of VA ECMO, but survival outcomes have not improved. Stringent selection and optimal timing of deployment are critical to improve mortality and morbidity of the patients supported with VA ECMO. MDPI 2021-04-08 /pmc/articles/PMC8068254/ /pubmed/33917910 http://dx.doi.org/10.3390/jcm10081573 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bhaskar, Priya Davila, Samuel Hoskote, Aparna Thiagarajan, Ravi Use of ECMO for Cardiogenic Shock in Pediatric Population |
title | Use of ECMO for Cardiogenic Shock in Pediatric Population |
title_full | Use of ECMO for Cardiogenic Shock in Pediatric Population |
title_fullStr | Use of ECMO for Cardiogenic Shock in Pediatric Population |
title_full_unstemmed | Use of ECMO for Cardiogenic Shock in Pediatric Population |
title_short | Use of ECMO for Cardiogenic Shock in Pediatric Population |
title_sort | use of ecmo for cardiogenic shock in pediatric population |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068254/ https://www.ncbi.nlm.nih.gov/pubmed/33917910 http://dx.doi.org/10.3390/jcm10081573 |
work_keys_str_mv | AT bhaskarpriya useofecmoforcardiogenicshockinpediatricpopulation AT davilasamuel useofecmoforcardiogenicshockinpediatricpopulation AT hoskoteaparna useofecmoforcardiogenicshockinpediatricpopulation AT thiagarajanravi useofecmoforcardiogenicshockinpediatricpopulation |